These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 919991

  • 21. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT, Palshof T, Brahm M, Rahbek I.
    Ugeskr Laeger; 1977 Oct 31; 139(44):2632-5. PubMed ID: 929742
    [No Abstract] [Full Text] [Related]

  • 22. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV, Bartolucci AA.
    Eur J Cancer (1965); 1980 Oct 31; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract] [Full Text] [Related]

  • 23. Phase II study of combination cytotoxic chemotherapy in advanced breast cancer: 2 years' followup.
    Carmo-Pereira J, Teles AG, Costa FO, Pimentel P.
    Cancer Treat Rep; 1976 Jan 31; 60(1):107-9. PubMed ID: 187339
    [No Abstract] [Full Text] [Related]

  • 24. Therapy of primary breast cancer.
    Holland JF.
    Isr J Med Sci; 1977 Aug 31; 13(8):829-36. PubMed ID: 893066
    [No Abstract] [Full Text] [Related]

  • 25. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA, Grillo-López A, Vélez-Garciá E.
    Bol Asoc Med P R; 1975 Jun 31; 67(6):157-63. PubMed ID: 1055588
    [No Abstract] [Full Text] [Related]

  • 26. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT.
    Ugeskr Laeger; 1973 Jun 18; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract] [Full Text] [Related]

  • 27. Adjuvant chemotherapy of breast cancer.
    Carter SK.
    N Engl J Med; 1981 Jan 01; 304(1):45-7. PubMed ID: 7001243
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The polychemotherapeutic treatment of advanced breast cancer.
    Brown I, Arthur K, Banks AJ, Bond WH, Chowdhury MS, Freeman WE, Holme GM, Jones WG, Newsholme GA, Ward HW.
    Clin Oncol; 1977 Jun 01; 3(2):183-9. PubMed ID: 872472
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of hepatic metastases from breast cancer.
    Bugarski M, Vuletić L, Boberić J, Milosavljević A, Dilparić S, Tomin R, Naumović P.
    Clin Oncol; 1978 Jun 01; 4(2):167-71. PubMed ID: 668248
    [No Abstract] [Full Text] [Related]

  • 31. Breast cancer 1984: state of the art.
    Sledge GW.
    Indiana Med; 1984 Dec 01; 77(12):935-9. PubMed ID: 6394645
    [No Abstract] [Full Text] [Related]

  • 32. [Preliminary results of a continuous study protocol with adjuvant chemotherapy in primary operable breast carcinoma].
    Cavalli F, Jungi F, Alberto P, Martz G, Brunner KW.
    Haematol Blood Transfus; 1978 Dec 01; 22():61-6. PubMed ID: 374200
    [No Abstract] [Full Text] [Related]

  • 33. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W, Nagel G, Senn HJ.
    Schweiz Med Wochenschr; 1974 Aug 03; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract] [Full Text] [Related]

  • 34. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA, Pearson OH, Marshall JS, Rhodes RS, Debanne SM, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL.
    Eur J Cancer (1965); 1980 Aug 03; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract] [Full Text] [Related]

  • 35. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
    Sanuki-Fujimoto N.
    Cancer Treat Rev; 2005 Oct 03; 31(6):496-500. PubMed ID: 16199127
    [No Abstract] [Full Text] [Related]

  • 36. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B, Kamby C.
    Ugeskr Laeger; 2007 Sep 10; 169(37):3070-2. PubMed ID: 17877950
    [Abstract] [Full Text] [Related]

  • 37. Nursing the woman receiving adjuvant chemotherapy for breast cancer.
    Laatsch N.
    Nurs Clin North Am; 1978 Jun 10; 13(2):337-49. PubMed ID: 248746
    [No Abstract] [Full Text] [Related]

  • 38. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW, Martz G, Senn HJ, Obrecht P, Alberto P, Melchert F.
    Internist (Berl); 1973 Dec 10; 14(12):643-52. PubMed ID: 4593011
    [No Abstract] [Full Text] [Related]

  • 39. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
    Jaremko M, Justenhoven C, Schroth W, Abraham BK, Fritz P, Vollmert C, Illig T, Simon W, Schwab M, Brauch H.
    Pharmacogenet Genomics; 2007 Jul 10; 17(7):529-38. PubMed ID: 17558308
    [Abstract] [Full Text] [Related]

  • 40. Cytotoxic agents in the treatment of malignant disease.
    Br Med J; 1968 Nov 16; 4(5628):438-9. PubMed ID: 4972069
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.